{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260608815972/en/U.S.-FDA-Approves-Pfizer%E2%80%99s-HYMPAVZI-for-the-Treatment-of-Two-Additional-Hemophilia-A-or-B-Patient-Populations-with-Significant-Medical-Need", "message": "News view counter 785669 successfully enlarged"}